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Abstract
Initiation, growth, recurrence, and metastasis of head and neck squamous cell carcinomas (HNSCC) have been related to
the behavior of cancer stem cells (CSC) that can be identified by their aldehyde-dehydrogenase-isoform-1 (ALDH1)
activity. We quantified and enriched ALDH1
+ cells within HNSCC cell lines and subsequently characterized their
phenotypical and functional properties like invasion capacity and epithelial-mesenchymal transition (EMT). Spheroid
culture enriched CSC from five HNSCC cell lines by up to 5-fold. In spheroid-derived cells (SDC) and the parental
monolayer-derived cell line ALDH1, CD44, CD24, E-Cadherin, a-SMA, and Vimentin expression was compared by flow-
cytometry and immunofluorescence together with proliferation and cell cycle analysis. Invasion activity was evaluated by
Matrigel assay and expression of stemness-related transcription factors (TF) Nanog, Oct3/4, Sox2 and EMT-related genes
Snail1 and 2, and Twist by real-time PCR. All cell lines formed spheroids that could self-renew and be serially re-passaged.
ALDH1 expression was significantly higher in SDC. ALDH1
+ cells showed increased colony-formation. The proportion of
cells with a putative CSC marker constellation of CD44
+/CD24
2 was highly variable (0.5% to 96%) in monolayer and
spheroid cultures and overlapped in 0%–33% with the CD44
+/CD24
2/ALDH1
+ cell subset. SDC had significantly higher
invading activity. mRNA of the stemness-related genes Sox2, Nanog, and Oct3/4 was significantly increased in SDC of all
cell lines. Twist was significantly increased in two while Snail2 showed a significant increase in one and a significant
decrease in SDC of two cell lines. SDC had a higher G0 phase proportion, showed high-level expression of a-SMA and
Vimentin, but significantly decreased E-Cadherin expression. HNSCC-lines harbor potential CSC, characterized by ALDH1
and stemness marker TF expression as well as properties like invasiveness, quiescence, and EMT. CSC can be enriched by
anchorage-independent culture techniques, which may be important for the investigation of their contribution to therapy
resistance, tumor recurrence and metastasis.
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Introduction
HNSCC accounts for approximately 6% of all cancer cases and
for about 650,000 new cases and 350,000 deaths worldwide each
year [1,2,3]. Advances in therapy have improved quality of life, but
survival rates have remained unchanged over the past decades.
Mortality from this disease remains high because of the develop-
ment of distant metastases and the emergence of local and systemic
recurrences resistant to chemo- and radiotherapy. It is therefore
essential to develop a deeper understanding of the biology of this
disease in order to develop more effective therapeutic approaches.
Evidence has recently been accumulating to support the
hypothesis that tumors contain a small subpopulation of cells
called cancer stem cells (CSC), which exhibit self-renewing
capacities and are responsible for tumor maintenance and
metastasis [4]. CD44
+/CD24
2cells have been firstly proposed to
exhibit CSC properties in breast cancer [5].
Subsequently, CD133 was found to identify CSC in brain
tumors [6], colorectal carcinoma [7], and pancreatic carcinoma
[8]. In HNSCC, Prince et al. first demonstrated that a CD44
+
population of cells possesses the properties of CSC [9], but
relatively high numbers of these cells (.5,000 cells) were needed to
generate new tumors in immunodeficient mice indicating either a
low frequency of CSC or a low specificity of CD44 as CSC-marker
in HNSCC. The latter hypothesis is supported by the observation
that CD44s and CD44v6 expression does not distinguish normal
from benign or malignant epithelia of the head and neck. CD44s
and CD44v6 were abundantly present in the great majority of cells
in head and neck tissues, including carcinomas [10]. Thus, the
identification of more specific CSC markers for HNSCC is
desirable. Recently, high aldehyde dehydrogenase 1 (ALDH1, also
known as ALDH1A1) activity was shown to identify the CSC in
HNSCC and other epithelial cancers [11,12,13,14,15]. However,
in breast cancer the ALDH1
+ population shows a surprisingly
PLoS ONE | www.plosone.org 1 January 2011 | Volume 6 | Issue 1 | e16466small overlap with the previously described CD44
+/CD24
2
phenotype of only 0.1–1.2%. Interestingly, in breast cancer the
cells bearing both phenotypes appeared to be highly tumorigenic,
being able to generate tumors from as few as 20 cells [15]. It
remains to be determined if the same phenotypic pattern of stem
cells in HNSCC is associated with a similar tumorigenic potential.
Non-adherent sphere assays are increasingly being used to
evaluate stem cell activity in normal tissue and putative CSC. The
neurosphere is the best-studied sphere assay. Central nervous
system cells grown on nonadherent surfaces give rise to neuro-
spheres that have the capacity for self-renewal and can in principal
generate all the cell types of the brain [16,17]. The capacity for
repeated generation of neurospheres from single cells is generally
viewed as evidence of self-renewal [18]. Recently, it was described
that spheroid-derived cells (SDC) from gliosarcoma rat cell lines
possess CSC capacity [19]. So far, it is unknown whether spheroid
cultures of HNSCC can enrich for CSC.
Normal hematopoietic stem cells are able to self-renew and give
rise to all blood cell types. They are non- or very slow-dividing
cells and reside within bone marrow niches in a dormant
condition. The ability to maintain this non-dividing condition,
or in other terms, stay in the G0 phase of cell cycle, is called
quiescence [20]. It has been proposed that CSC share many
qualities with normal stem cells since the vast majority of them also
should stay quiescent and be able to self-renew. Because a majority
of anti-cancer drugs target actively dividing (cycling) cells,
quiescent CSC remain alive and may be the cause for relapses
and progression of cancer. Ki-67 antigen is the prototypic cell
cycle related nuclear protein, expressed by proliferating cells in all
phases of the active cell cycle (G1, S, G2 and M phase), but it is
absent in resting (G0) cells.
Another capability of CSC is to perform epithelial–mesenchy-
mal transition (EMT), a key step during embryogenesis [21,22,23]
and wound healing [24]. Recent evidence suggests that genetic
programs relevant for EMT are also transiently activated in
epithelial cancers playing a role in cancer progression, through
which epithelial cancers invade tissues and metastasize. Although
the EMT program is necessary for normal development, the
aberrant activation of EMT contributes to various pathologic
conditions, including fibrosis and carcinoma progression [25,26].
During EMT epithelial cells break down cell-cell and cell-
extracellular matrix contacts and migrate to other locations in
the body [27]. During cancer progression, EMT seems to provide
cancer cells with the capacity to infiltrate the surrounding tissue
and ultimately metastasize to distant sites [28]. Recently, it has
been reported that the induction of EMT in differentiated
Figure 1. Spheroids generated from HNSCC lines in serum-free medium have self-renewing capacity. Representative pictures of the cell
line UD-SCC1 are shown. (A) The first generation of spheroids. (B) A subspheroid formed after seeding at a concentration of 1,000 cells/ml. (C)A
spheroid formed in the 21st generation. (D) Spheroid adhering and growing to confluence after replating into flasks coated for tissue culture. (E)
Parental cell line grown permanently as a monolayer culture.
doi:10.1371/journal.pone.0016466.g001
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Comparison of frequencies of ALDH1 positive cells in monolayer to SDC and DEAB control. DEAB is a specific inhibitor of ALDH1. (B) The results
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acquisition of the CD44
+/CD24
2 stem cell phenotype [29].
Moreover, it was shown that these putative CD44
+/CD24
2 CSC
isolated from neoplastic human breast tissues expressed high
mRNA levels encoding the EMT-associated markers Snail1
(SNA), Snail2, and Twist. Malignant tumors consist of cancer
cells and tumor-associated host cells, with the latter attracting
more interest recently because of their participation in tumor
invasion and metastasis, and therapeutic response [30,31].
Myofibroblasts are the most important components of the tumor
stroma. Nevertheless, the origin of these cells remains controversial
so far. The expression of alpha-smooth muscle actin (a-SMA)
is considered the marker of the fully differentiated myofibroblasts.
Emerging evidence shows that myofibroblasts can be derived
from the epithelial (tumor) cells via EMT [32,33]. This notion
is supported by the observation that compact spheroids formed
by ovarian cancer cells in ascites display contractile behavior,
possess high invading capacity in vitro and the expression of
a-SMA, which is also associated with high contractile capacity
[34].
In the present work, we tested if anchorage-independent cell
culture techniques allow the generation of spheroid-cultures and if
represent the expression of ALDH1 in cells derived from spheroid cultures (hedged columns) compared to monolayer cells (open columns). ALDH1
expression of SDC is generally significantly enhanced (A, B). UD-SCC22, UT-SCC24A, and UM-SCC11B displaying a partial mesenchymal phenotype
have already relatively high ALDH1 expression in parental cell lines. (** p,0.01, * p,0.05).
doi:10.1371/journal.pone.0016466.g002
Table 1. CD44
+/CD24
2 phenotype is highly variable in HNSCC and does not consistently overlap with the ALDH1
+ subpopulation.
Frequency (%) UD-SCC1 UT-SCC9 UT-SCC24A UT-SCC22 UM-SCC11B
CD44
+/CD24
2 in monolayer cultures 0.4460.13 0.1160.07 0.9860.2 95.2760.8 95.461.25
CD44
+/CD24
2 in
spheroid cultures
0.9660.71 3.2863.54 0.8860.19 95.1761.46 96.4761.62
ALDH1+/CD44
+/CD24
2 in monolayer cultures 0.1160.1 0.0860.13 0.3660.33 19.0761.17 17.3763.33
ALDH1+/CD44
+/CD24
2 in spheroid cultures 0.6660.52 2.2262.61 0.5360.41 33610.66
* 33.463.04
**
(Data were stated as: mean6standard deviation, %=proportion of positive cells, *p,0.05, **p,0.01).
doi:10.1371/journal.pone.0016466.t001
Figure 3. Clone formation assay with FACS-sorted and cloned cells. Two thousand ALDH1-sorted cells were seeded and after 14 days, the
colonies that formed were quantified. The ALDH1
+ subpopulation in UD-SCC1 and UT-SCC9 cell lines have a higher clone formation efficiency as
compared to the ALDH1
2 subpopulation (** p,0.01).
doi:10.1371/journal.pone.0016466.g003
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phenotypic properties characterizing CSC of HNSCC. Here, we
provide evidence that myofibroblasts can be derived from
HNSCC using a spheroid cell culture model that enriches for
CSC-like cells as characterized by a high proportion of ALDH1
positivity, proliferative quiescence, and invasive capacity.
Results
HNSCC cell lines contain cells with self-renewing
capacities that form tumor spheroids
Several different approaches have been used to identify CSC.
The strategy used for our experiments was the in vitro spheroid
Table 2. Single ALDH1
+ cells show higher clone formation activity than ALDH1
2 cells.
Spheroid-formation Name of cell line
UT-SCC9 ALDH1- UT-SCC9 ALDH1+ UD-SCC1 ALDH1- UD- SCC1 ALDH+
Yes 1 19 0 23
No 135 92 104 96
Sum 136 111 104 119
Formation Rate 0.7% 17.10%* 0% 19.30%**
Analyzed by chi-square test,
*p,0.05,
**p,0.01.
doi:10.1371/journal.pone.0016466.t002
Figure 4. ECM invasion assay. Matrigel invasion chambers were used to compare the invading capacity between cells derived from spheroids
(hatched columns) or monolayer (open columns). SDC from all cell lines investigated show higher invading activity in vitro than monolayer-derived
cells. (** p,0.01, * p,0.05).
doi:10.1371/journal.pone.0016466.g004
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HNSCC-derived cell lines (UD-SCC1, UT-SCC22, UM-
SCC11B, UT-SCC9, UT-SCC24A) to grow anchorage indepen-
dently as spheroid-cultures. Cells were plated at a density of
20,000/ml. After in vitro culture for 5–10 days in serum-free
medium under nonadherent conditions, all investigated cell lines
formed spheroids, ranging from 50 to 500 cells per spheroid
(Figure 1A). The self-renewing capacity of these tumor spheroids
was assessed using the method published by Ghods et al [19].
Briefly, the spheroids were collected and dissociated into a single
cell suspension that was subsequently plated at a clonal density of
1,000 cells per ml. Tumor subspheroids ranging from 20 to 40 cells
were evident after 10 to14 days (Figure 1B, C). In contrast, the
parental monolayer cell cultures grown under the same conditions
did not form spheroids if plated at this low concentration even
after 21 days. When the spheroids were transferred back to a
regular tissue culture flask coated for monolayer cell culture, the
spheroids adhered to the flask and cells grew out from the spheroid
and formed a confluent monolayer. The phenotype of these cells
was identical to the parental cell lines (Figure 1D).
Phenotypic characterization of SDC
The expression of the putative stem cell marker ALDH1 in
SDC and the respective parental monolayer cell line used as
control was compared to the CD44
+/CD24
2 expressing popula-
tion by multicolor FACS-analysis.
Interestingly, all SDC had an increased number of ALDH1
positive cells as compared to parental cell lines (Figure 2). The
highest proportion of ALDH1
+ cells was found in spheroids
generated from the UD-SSC1 cell line (46.468.1%) which was 5-
fold higher than the corresponding parental cell line (9.465.3%).
Tumor cells with a CD44
+/CD24
2 phenotype were shown to
have CSC properties in a variety of solid tumors [4]. We therefore
also investigated comparatively the CD44 and CD24 expression in
HNSCC cell lines and found that the proportion of CD44
+/
CD24
2 cells is highly variable (0.5–97%). The overlap with
ALDH1
+ cells was small (0–2.2%) except for the two cell lines
UM-SCC11B and UT-SCC22 which had an overlap of about
33% and were composed to over 95% of CD44
+/CD24
2 cells.
Interestingly, the proportion of CD44
+/CD24
2 cells was not
consistently enriched by the spheroid culture method (Table 1).
This result raised the question how well ALDH1 is suited for the
identification of cells with CSC properties in HNSCC. To
approach this question, ALDH1 positive and negative cells from
the spheroids generated from the cell lines UT-SCC9 and UD-
SCC1 were separated by FACS sorting. Subsequently, their
capacity for colony formation was assessed. UT-SCC9 and UD-
SCC1 were chosen because as compared to the other cell lines
they generated more spheroids with higher enrichment of
ALDH1
+ cells. The data show that ALDH1
+ cells can form 3 to
4 times more clones than ALDH1
2 cells (Figure 3). Light
microscopic observation after 2 weeks showed that the clones
formed by ALDH1
+ cells on average contained 197 (197647) cells
compared with 33 (33616) cells in clones generated from
ALDH1
2 cells (p,0.01). Our data also show that single ALDH1
+
cells can significantly better regenerate a spheroid in an
anchorage-independent culture with serum-free medium comple-
mented with bFGF and EGF (UT-SCC9: 17.1%, UD-SCC1:
19.3%), whereas under the same conditions single ALDH1
2 cells
regenerated only in one case a spheroid. (Table 2, Figure S1).
In summary, SDC generated from HNSCC lines express high
levels of the putative CSC marker ALDH1, form significantly
more clones, which also significantly regenerate more often into
spheroids then ALDH1
2 cells and have a varying overlap with the
CD44
+/CD24
2 population.
SDC show increased invading capacity in vitro
Central to the definition of CSC is the capability to initiate and drive
the growth of the primary tumor and of invasion and metastasis. A
close relationship between the percentage of cells with CSC phenotype
(CD44
+/CD24
2) in the primary tumor and the development of
metastasis in breast-cancer was recently reported [35]. Also, indication
for the metastatic potential of cells with CSC-phenotype in breast
cancer comes from the observation that breast cancer cells detected in
the bone marrow predominantly showed this phenotype [36].
In analogy to this observation, we asked whether CSC derived of
spheroid cultures of HNSCC display a similar invasive potential. By
using a Matrigel invasion chamber, we compared the invading
capacity of cells either raised in spheroid or monolayer culture. SDC
from all five tested cell lines showed a significantly increased invading
capacity of 2.1 to 8.6 fold over the parental control (Figure 4).
Overexpression of stemness-related genes in SDC
It was reported that Oct4, Sox2, and Nanog, which form a self-
organized core of transcription factors (TF), maintain pluripotency
and self-renewal of human embryonic stem cells [37,38]. We
wanted to know if CSC also share this feature of TF expression
with embryonal stem cells (ES). For this purpose, we quantitatively
compared the mRNA expression of these TF between SDC and
parental monolayer-derived cells. We found that the mRNA levels
of Oct3/4, Sox2, and Nanog were all significantly increased in the
SDC. The highest increase was observed in UT-SCC22, where a
52-fold increase in Sox2 expression was found in spheroids. The
smallest change was found in UT-SCC9, where a 1.23-fold
increase in Oct3/4 expression was found in spheroids. The key TF
involved in EMT, Snail1 was also significantly increased in all
SDC generated from the five different HNSCC cell lines.
Interestingly, two other TF involved in EMT, Snail2 and Twist,
showed an expression pattern in accordance with the CD24 status.
In UD-SCC1, UT-SCC9, and UT-SCC24A where most of the
cells are CD44
+/CD24
+, the Snail2 level decreased in spheroids
while Twist showed no significant change. However, in UT-
SSC22 and UM-SCC11B, which were composed to over 95% of
CD44
+/CD24
2 cells Snail2 and Twist, showed a significant
increase (Figure 5). These findings implied that Snail2 and Twist
expression level were correlated to the CD24 phenotype.
SDC are more quiescent than their parental monolayer-
derived counterparts
For cell cycle analysis by FACS, the cell lines UT-SCC24A,
UT-SCC9, UD-SCC1, UT-SCC22, and UM-SCC11B grown in
spheroid or monolayer culture were stained for Ki-67-FITC and
DNA counterstained by propidium iodide. Cells residing in the
Figure 5. Quantitative PCR analysis of mRNA expression of stemness-related transcription factors. Messenger RNA isolated from
spheroids and monolayer cultures was quantified for expression of the indicated TF. The ratio of expression in spheroid to monolayer cells is given.
Significant differences were * p,0.05; ** p,0.01. The mRNA level of stemness-related TF Nanog, Oct3/4, and Sox2 were increased remarkably in
spheroids. The key TF in EMT Snail1 was also increased in all spheroids but another two TF involved in EMT, Snail2 and Twist, showed an expression
pattern depending on the CD44/CD24 status.
doi:10.1371/journal.pone.0016466.g005
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to be the quiescent fraction (G0 phase). In all cell lines, the
proportion of cells in the G0 phase showed a highly significant
increase in SDC, indicating that SDC contain a higher proportion
of quiescent cells than parental monolayer-derived cells (Figure 6).
A subpopulation of cells in spheroids have acquired
features of myofibroblasts and may have undergone EMT
Myofibroblasts are components of the tumor stroma and may
have a role in constructing the CSC-niche, which may help to
preserve the stemness of CSC. Nevertheless, the origin of these
cells remains unknown. Myofibroblasts produce several factors,
which may stimulate proliferation of cancer cells and facilitate
infiltration of tissue. In the literature, non-adherent spheroids
generated from cancer cell lines have been shown to contain
putative CSC. These spheroids could be maintained in culture for
long periods, which implies that the spheroids may provide a niche
suitable for the maintenance and growth of CSC. Therefore, we
asked if i) myofibroblasts exist in the niche created by spheroids, ii)
are these myofibroblasts derived from epithelial tumor cells
through EMT, and iii) are there indications that this process is
reversible?
To address this matter, we investigated the expression of
myofibroblast markers Vimentin and a-SMA in SDC of 3 cell lines
which have different ALDH1 expression levels in monolayer
culture (low: UD-SCC1: 9.465.3%, medium: UT-SCC22:
16.964.1%, high: UT-SCC24A: 25.863.0%). We found that
the different cell lines and SDC generated from these cell lines
varied in the proportion of cells expressing Vimentin and a-SMA
(Table 3). UD-SCC1 showed no a-SMA expressing cells and weak
(12.562.5%) Vimentin expression of the cells in the monolayer
culture. In contrast, UT-SCC24A (Figure 7) and UT-SCC22
monolayer-derived cells had a relatively high frequency of
Vimentin and a-SMA expressing cells which indicates that these
cell lines have both epithelial and mesenchymal characteristics.
Interestingly, these two cell lines have a relatively high percentage
of cells in the monolayer cultures that are ALDH1 positive
(Table 3). Nevertheless, as spheroid cultures, all cell lines
contained more a-SMA and Vimentin positive cells than the
corresponding parental monolayer cell lines.
EMT is also accompanied by loss of cell-cell contacts to
epithelial cells, characterized by a down-regulation of E-Cadherin
expression. The number of E-Cadherin expressing cells in SDC
and monolayers was quantified by FACS (Figure 7, Table 3). The
SDC showed significantly increased proportions of E-Cadherin
negative to low expressing cells compared to their monolayer-
derived counterparts, indicating loss of cellular adherence in this
subpopulation.
Finally, we also tested the re-adhesion of spheroids to culture
plastic. Interestingly, when the spheroids attached to the flask and
began to grow out as a monolayer culture, the a-SMA and
Vimentin level decreased, and most of the cells that grew out from
the spheroids stained negative for these two markers (Figure 8).
Discussion
In tumor biology many efforts have been made to explain the
embryonal-like features of transformed cancer cells. The ability of
CSC to rebuild the tumor from a single cell could explain many of
the differences that discriminate tumor cells from differentiated
somatic cells like immortality, quiescence, invasion leading to
metastasis, and recurrence after treatment. Prince and colleagues
[9], demonstrated that a minor population of CD44
+ HNSCC-
cells possess CSC characteristics, which could give rise to new
tumors in vivo (<5,000 cells injected). Mack and colleagues
questioned the use of CD44 as a specific CSC marker in HNSCC
since CD44 was abundantly expressed in most tumor cells within
HNSCC (60%-100%) and therefore could not be used to
distinguish normal from benign or malignant epithelia of the
head and neck [10]. ALDH1 was recently shown to be a more
suitable marker to identify putative CSC of HNSCC and other
epithelial cancers [11,12,13,14,15]. In HNSCC, Chen et al
showed that 3000 ALDH1
+ HNSCC cells from five patients in
xenotransplanted mice resulted in all cases in the generation of
visible tumors 6 weeks after injection, while 10
4 ALDH1
2 cells
failed to generate tumors. [12,39]. We describe a method for the
propagation and enrichment of ALDH1
+ cell cultures of HNSCC
cell lines. The stem cell-like characteristics of these cells were
analyzed by comparing surface antigen expression and the
expression of embryonal TF as well as functional characteristics
of the parental monolayer cell lines. The observation that
spheroid-cultures do not consist of a homogeneous cell population
triggered further subanalyses that revealed a cell population with
expression of EMT-markers. This may indicate that these cells
have an activated EMT-program and demonstrates a potentially
close relationship between CSC and cells with an activated EMT
program which may have derived from the CSC.
Spheroids are three-dimensional (spherical) clusters of tumor
cells grown from one or several cell clones. As compared to cell
doubling times measured in monolayer culture, the rate and
pattern of spheroid growth in vitro better matches that observed in
tumors in vivo [40]. Anchorage independent growth has been
shown to be a property shared by normal tissue cells that exhibit
stem cell properties [41]. Also CSC derived from melanoma [42],
breast cancer [43], and gliosarcoma [19] were able to be
propagated anchorage independently and display the phenotype
of nonadherent spheroids.
As exemplified in breast cancer for example, putative CSC
(CD44
+/CD24
2) can be enriched in-vitro by isolating mammo-
spheres fromsuspensioncultures [43,44].Inourstudy,wefound the
frequency of CD44
+/CD24
2 cells in HNSCC lines to be highly
variable (from 0.5% to 97%). Moreover, they could not be enriched
byspheroidculture.Incontrast,ALDH1positivecellswerefoundto
be highly enriched in spheroid cultures from all five HNSCC cell
lines. If seeded at a very low densitiy, FACS sorted ALDH1
+ cells
formed significantly more colonies then the ALDH
2 population,
indicating a higher proliferative capacity of this subpopulation.
Others have shown, that ALDH1
+ or ALDH1
+/CD44
+/CD24
2
cell populations isolated from HNSCC-patients have a higher
tumorigenic potential then ALDH1
2 cells even if they were
CD44
+24
2 if xenotransplanted in mice [12].
Cancer and normal stem cells (SC) share proliferative properties
of self-renewal, quiescence and expression of key transcription
factors (TF). Chickarmane et al. [45] set up a computer-model to
describethekeytranscription factor combinationsinSCand defined
high levels of Oct3/4, Sox2, and Nanog. On the other hand, Ji et al.
Figure 6. Cell cycle analysis of SDC and monolayer-derived cells by FACS analysis. (A) Double staining with Ki-67 and propidium iodide for
the measurement of proliferation and cellular DNA content. Single cells were gated on FL2-W and FL2-A. DNA content and Ki-67 expression was
evaluated by flow cytometry analysis. (B) Frequencies of quiescent cells in SDC as comparison to monolayer-derived cells. In all cases, the cells
derived from spheroids contain a highly significant larger percentage of quiescent (G0) cells. (** p,0.01).
doi:10.1371/journal.pone.0016466.g006
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hPSCs), and normal human pluripotent stem cells (hPSCs). Unlike
normal SC, self-renewal and survival of t-hPSCs was found to be
independent of Oct3/4 expression. In contrast, genetic knockdown
of Nanog caused complete loss of self-renewal concomitantly with
apoptosis in t-hPSCs. In our study, the expression of Oct3/4, Sox2,
and Nanog was up-regulated in SDC in the five HNSCC derived
cell lines. This implies that SDC may have stem cell properties.
Studies dealing with gene expression profiling using in vivo
invasive cells or cells undergoing EMT in vitro, revealed a switch
from a proliferative to an invasive phenotype. In agreement to this
observation, the cell proliferation marker Ki-67 has been shown to
label only a small minority of cells at the invasive front as
compared to the more differentiated central part of the tumor,
suggesting that non-proliferating tumor cells that have escaped the
tumor mass could have metastatic potential [47]. In our study, we
found that SDC had a higher proportion of Ki-67 negative cells
compared to the corresponding monolayer cultures. This indicates
that SDC are more quiescent than cells derived from monolayer.
We also found that SDC have an increased invasion capacity,
which implies that these cells may have a higher ability to
metastasize.
Myofibroblasts are a kind of mesenchymal cell playing a key
role in tumor invasion and metastasis and therapeutic response.
They can produce several factors which may stimulate prolifer-
ation of cancer cells and facilitate their infiltration [31]. However,
the origin of these myofibroblasts is not clear. EMT has been
reported to play an important role in initiating CSC [29]. In this
study, we demonstrated that the myofibroblast-like cells are a
subpopulation of SDC. These spheroids derived exclusively from
cloned tumor cells. It can therefore be concluded that the
myofibroblasts could only emerge from epithelial cancer cells by
altering the epithelial to a mesenchymal phenotype through EMT.
More importantly, as we found, that over 90% of SDC stained
positive for a-SMA and Vimentin while the percentage of
ALDH1
+ cells ranged from 37% to 46.4%. A significant decrease
of E-Cadherin expression could be demonstrated in SDC,
indicating a reduction of cell-cell contact in spheroid cultures.
These marker expressions were reversible under culture condi-
tions, where spheroids could adhere and cells grew radially out to
form a monolayer. Taken together, these data indicate that
spheroid cultures contain at least two populations that at their
extremes may have either CSC- or mesenchymal characteristics,
while many cells are in transition between these phenotypes. We
believe that cells derived from spheroids, which had undergone a
transition to a mesenchymal phenotype, maintained CSC-
characteristics such as expressing a high level of the CSC marker
ALDH1, an increased proportion of G0 phase cells, increased
invading capacity, and elevated mRNA levels of stem cell-related
transcription factors such as Nanog, Sox2, and Oct3/4.
In summary, in this study we provide an anchorage indepen-
dent culturing method of HNSCC cell lines suitable for the
enrichment of cells with cancer stem cell characteristics and of cells
undergoing EMT. Whether this method would select, starting
from non-manipulated human HNSCC samples, the tumorigenic
cells remains to be demonstrated. Functionally, SDC showed
higher invading capacity than monolayer cells. FACS sorted
ALDH1
+ cells showed higher colony forming ability than
ALDH1
2 cells. Our findings may prove useful to investigate the
phenomenon of EMT in vitro and thus support in vivo studies
investigating the role of CSC and EMT in the spread of HNSCC.
Materials and Methods
Cell lines
The HNSCC cell line panel was composed of UD (University of
Du ¨sseldorf, Henning Bier) -SCC 1, UM (University of Michigan,
Tom Carey) -SCC -11B and UT (University of Turku, Reidar
Grenman) -SCC -9, -22, -24A [48,49]. The suffixes A, B, and C
indicate cell lines derived from the primary tumor (A), metastatic (B)
orrecurrent(C)disease.TheseimmortalHNSCClineshavebeenin
culture from primary tumorfor approximately 40 to 60 generations.
Suspension culture for spheroid formation
Adherent monolayer cells were grown in normal 25 cm
2 culture
flasks (TPP, Switzerland) in DMEM (Gibco, Paisley, UK)
supplemented with GlutaMAXTM-I, 1x containing 10% heat
inactivated FCS and 1% Penicillin/Streptomycin, until con-
fluency. Cells were washed with PBS twice and detached using
Trypsin/EDTA solution. The reaction was stopped by adding
complete culture medium. After 5 minutes, cells were resuspended
in serum-free Quantum 263 medium (Biochrom AG, Berlin,
Germany), supplemented with 10 ng/ml EGF and 10 ng/ml
bFGF (Biochrom).
Figure 7. Analysis of the expression of a-SMA and Vimentin expression by immunofluorescence and E-Cadherin by FACS of
monolayer versus SDC. (A) Immunofluorescence staining of monolayer (A1-3 and B1-3) and spheroid (C1-3 and D1-3) cultures from UT-SCC24A
with antibodies directed against a-SMA (green) and Vimentin (red). All of the SDC (panel C and D) show high levels of the mesenchymal markers a-
SMA and Vimentin compared to their monolayer counterparts. (B) E-Cadherin expression analysis by FACS. Compared to their monolayer
counterparts, spheroids showed decreased E-Cadherin expression; two populations of cells derived from UT-SSC24A can be separated according to
the E-Cadherin expression level, which indicates that the SDC have acquired myofibroblast characteristics by EMT.
doi:10.1371/journal.pone.0016466.g007
Table 3. Relative expression of EMT markers by monolayer and SDC-derived cells.
a-SMA Vimentin E-Cadherin ALDH1
UD-SCC1 Monolayer SDC
1 no expression SDC: .90% 12.562.5% SDC: .90% 95.462.8% 83.563.1%
** 9.465.3% 46.468.1%
**
UT-SCC24A Monolayer SDC 6.061.4% SDC: .90% 36.365.3% SDC: .90% 62.464.5% 49.065.6%
* 25.863.0% 42.568.7%
*
UT-SCC22 Monolayer SDC 23.763.0% SDC: .90% 42.765.3% SDC: .90% 84.364.2% 63.165.0%
** 16.964.1% 37.0611.9%
*
1)due to superposition cell proportions were estimated.
**P,0.01,
*P,0.05.
doi:10.1371/journal.pone.0016466.t003
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Low Attachment plates (Fisher Scientific, Loughborough, UK) at a
specific density of 2610
4 cells/ml. Cells were kept in the incubator
at 37uC in humidified atmosphere with 5% CO2 content. At day
three, half of the medium was replaced. After 5 to 7 days,
representative pictures were taken and spheroids were collected by
filtration through a 40 mm mesh for the following experiments.
Multicolor flow-cytometric (FACS) analysis and sorting
The identification of aldehyde dehydrogenase 1 (ALDH1)
activity from spheroid-derived and HNSCC monolayer cells was
conducted by using the ALDEFLUOR assay (StemCell Technol-
ogies, Durham, NC, USA). Spheroids were collected using a
40 mm mesh and disaggregated into single cells by Trypsin/EDTA
digestion for 10 min followed by 20 times up- and down pipetting
using a 1000 mm pipette tip. The single cell suspension was washed
twice in PBS buffer then suspended in ALDEFLUOR assay buffer
containing ALDH substrate (BAAA, 1 mol/l per 1610
6 cells) and
incubated for 40 min at 37uC. As a negative control, for each
sample of cells an aliquot was treated with 50 mmol/l diethyla-
minobenzaldehyde (DEAB), a specific ALDH inhibitor.
Next,forcellsurfaceantigenphenotyping,cellswereresuspended
in 100 ml Aldefluor incubation buffer then stained with 20 ml anti-
CD24-PE (BD bioscience, San Jose, CA, USA), 20 ml anti-CD44-
APC (BD bioscience) and 5 ml 7-AAD (BD bioscience) or 5 ml anti-
E-Cadherin (Biolegend, San Diego,CA, USA) per 10
6 cells. The
cells were then incubated at 4uC for 15 min in the dark. Following
incubation, cells were washed once with cold FACS buffer.
For FACS sorting, cells were resuspended in PBS buffer at
1610
7 cells per ml and separated on an Aria cell sorter (BD
Biosciences). The sorted cells could not be assessed for purity by
reanalysis due to the low numbers of cells obtained. The sorting
Figure 8. Changes in putative EMT marker expression upon reattachment of spheroids to an adhesive support. (A–C) Light-
microscopic images with phase contrast form UD-SCC1 spheroids reattaching to cover slides during the process of re-growth to a monolayer
phenotype. (A) 24 h after reattachment, some spindle-like cells grow out from adhered spheroids. (B) 72 h after reattachment, most of the attached
cells’ shape looks like their parental monolayer counterpart (C). (D–E) Indirect immunofluorescence staining of reattached spheroids after 24 h
stained with DAPI (D1, E1), a-SMA (D2; green), and Vimentin (E2; red). Pictures D3 and E3 show the overlay with nuclear staining. Arrows depict
outgrowing cells radiating from the spheroid. The expression of a-SMA and Vimentin decreased in outgrowing cells (arrows) after reattachment and
most of the staining was confined to spheroids while most of the cells grown from spheroids were unstained.
doi:10.1371/journal.pone.0016466.g008
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Clone formation assay
After FACS sorting, the ALDH1
+ and ALDH1
2 cells were
inoculated to 6-well plates at a density of 1000 cells/ml in DMEM
medium supplemented with 10% FBS. Cells were cultivated under
standard culture conditions for 2 weeks and then the clone
numbers were counted microscopically.
Spheroid culture is one of the three-dimensional culture systems
that have been reported. After FACS sorting, ALDH1
+ and
ALDH1
2 cells were inoculated into Ultra-low attachment 96-well
plates (Fisher Scientific, Loughborough, UK) by using the limiting
dilution method. All wells were examined carefully under
microscopical vision and the wells with more than one cell or no
cells were excluded from further analysis. Cells were resuspended in
serum-free Quantum 263 medium (Biochrom AG, Berlin, Ger-
many), supplemented with 10 ng/ml EGF and 10 ng/ml bFGF
(Biochrom). Fresh medium was added every week. After 3 weeks,
the cells contained in each well were counted and photographed.
Quantitative real-time PCR
Total RNA was extracted by using a Qiagen RNeasy kit
(Qiagen, Hilden Germany), then converted to cDNA with the
Omniscript First-Strand synthesis system (Qiagen) using random
primers (Qiagen). qRT-PCRs were carried out using ABI Power
SYBR Green mix (ABI, Applied Biosystems Inc, Foster City, CA,
USA) and run on a BioRad Chromo 4 (BioRad, Mu ¨nchen,
Germany). Reactions were carried out in Triplicate with RT
controls, the gene of Ribosomal protein HL32 was used as a
reference gene [50], and data were analyzed using the modified
delta delta Ct method. Primer sequences are listed in table 4.
Invasion assay
Cells cultivated in a monolayer or in a spheroid-culture were
separated into single cells by careful trypsin digestion and
resuspended in 1% BSA-DMEM culture medium. Cells (5610
4)
were seeded into the upper compartments of BD BioCoat
TM
Matrigel Invasion Chambers (BD Bioscience), and DMEM
supplemented with 10% FBS was added to the lower compart-
ment according to manufacturer’s instructions. The invasion
chamber was kept for 24 h under standard culture conditions.
After incubation, the non-invading cells were removed from the
upper surface of the membrane by gentle scrubbing, and the cells
on the lower surface of the membrane were stained with crystal
violet. Cell counting was facilitated by photographing the
membrane through the microscope and 3 fields per membrane
of triplicate membranes were counted under 2006magnification
(Axiovert, Axiovision, Zeiss, Germany).
Cell cycle analysis and Ki-67 staining
The parental cells and spheroids were harvested, dissociated
into single cells and resuspended in 70% ethanol by adding
ethanol at 220uC dropwise while vortexing. The cells were stored
at 220uC overnight then washed with PBS, centrifuged and 1 mg
FITC-conjugated mouse anti-human Ki-67 (DAKO, Glostrup,
Denmark) was added to the cell pellet and incubated for 20 min at
room temperature. Finally, cells were resuspended in 1 ml of a
cocktail containing propidium iodide (2 mg/ml) and RNAse
(100 mg/ml) (Fermentas Life Science, St. Leon-Rot, Germany)
and stained for 30 min followed by FACS analysis.
Immunofluorescence
Indirect immunofluorescence staining was performed on
spheroids and on parental adherent cultures of cancer cells for
a-SMA and Vimentin. Spheroids were collected by filtering the
suspension culture medium through a 40 mm mesh (BD biosci-
ence), and then whole spheroids were cytospined (1500 rpm,
5 min) onto slides. Cells were fixed in 4% paraformaldehyde then
permeabilized with 0.1% Triton in PBS solution for 10 min. First,
mouse anti-human Vimentin (1:50 from stock; Santa Cruz
Biotechnology, Heidelberg, Germany) and mouse anti-human a-
SMA diluted (1:50 from stock; Dako) antibodies were added and
incubated overnight at 4uC. Then the secondary antibody,
Alexa488-conjugated goat anti-mouse IgG (Invitrogen, Karlsruhe,
Germany) or Alexa568-conjugated donkey anti-mouse IgG (1:200
from stock) (Invitrogen), was added and incubated for 60 min at
room temperature. Counterstaining was performed by using DAPI
(1 mg/ml Roche, Mannheim, Germany). For quantification, the
average percentages of positive cells from three experiments were
estimated. Due to superposition in the case of SDC, cell
proportions are less reliable. Therefore, no significance was
calculated for Vimentin and a-SMA.
Supporting Information
Figure S1 Single ALDH1
+ cells proliferated and formed
a spheroid significantly more often then ALDH1
2 cells.
(A) FACS-sorting strategy for SDC of UD-SCC1. Representative
pictures of the cell line UD-SCC 1 are shown. (B) ALDH1
2 or
ALDH1
+ single cells were cultured in 96-well ultra-low attachment
plates. Three weeks after inoculation, 19.3% of ALDH1
+ SDCs
formed spheroids while ALDH1
2 cells failed to form spheroids
except for one case (p,0.01).
(TIF)
Table 4. Primer sequences used for RT-PCR in TF expression analysis.
Transcript name Forward primer sequence Reverse primer sequence
SNAIL1 GGCGCACCTGCTCGGGGAGTG GCCGATTCGCGCAGCA [51]
Nanog AATACCTCAGCCTCCAGCAGATG TGCGTCACACCATTGCTATTCTTC
SNAIL2 GGGGAGAAGCCTTTTTCTTG TCCTCATGTTTGTGCAGGAG
Twist1 GGAGTCCGCAGTCTTACGAG TCTGGAGGACCTGGTAGAGG
Oct3/4 GACAGGGGGAGGGGAGGAGCTAGG CTTCCCTCCAACCAGTTGCCCCAAAC
Sox2 GGGAAATGGGAGGGGTGCAAAAGAGG TTGCGTGAGTGTGGATGGGATTGGTG
hL32
(reference)
AGCTCCCAAAAATAGACGCAC TTCATAGCAGTAGGCACAAAGG [50]
doi:10.1371/journal.pone.0016466.t004
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